Results 11 to 20 of about 44,369 (290)
Safety and interaction of direct oral anticoagulants with antiarrhythmic drugs
The use of direct oral anticoagulants minimized the risks associated with vitamin K antagonist (warfarin) therapy. Currently, direct oral anticoagulants have priority over warfarin for the prevention of thromboembolic events in patients with atrial ...
B. A. Tatarsky, N. V. Kazyonnova
doaj +3 more sources
Safety issues of antiarrhythmic therapy for atrial fibrillation
The article discusses the safety of antiarrhythmic therapy for atrial fibrillation in the light of the development of cardiac and non-cardiac side effects, the presence of drug-drug interactions of antiarrhythmic drugs in the near (with anticoagulants ...
I.I. Reznik , Ya.G. Bozhko
doaj +2 more sources
Prediction of antiarrhythmic therapy effectiveness in children
Aim. To optimize treatment tactics in children with arrhythmias based on the evaluation and prediction of the therapy efficacy.Material and methods. Prospective cohort study was performed from 2007 to 2017 A total of 100 patients aged 0 to 7 years with ...
L. I. Svintsova +2 more
doaj +3 more sources
Current strategies of antiarrhythmic drug therapy for paroxysmal atrial fibrillation [PDF]
Atrial fibrillation is now recognized as a significant medical and social problem. Atrial fibrillation not only causes cardiovascular complications, including thromboembolism and heart failure, but also decreases the survival of patients with impaired ...
Takashi Komatsu
doaj +2 more sources
ANTIARRHYTHMIC ACTIVITY MONOGAMISTIC AMIDES AND HYDRAZIDES 1,4-DICARBOXYLIC ACIDS
The antiarrhythmic activity of 19 derivatives 1,4-dicarboxylic acids in experiments on white mice on the model of chlorocalcium arrhythmia and acute toxicity of 6 compounds. As a standard, the drug «Lidocaine» was used.
N. V. Kolotova, I. P. Rudakova
doaj +2 more sources
The work has studied opportunities for ТЕ EPS in serial testing of antiarrhythmic drugs testing to prevent recurrent arrhythmia in patients with atrial fibrillation.
K. A. Skiba, V. V. Petry, V. A. Sulimov
doaj +1 more source
CNP Promotes Antiarrhythmic Effects via Phosphodiesterase 2 [PDF]
Background: Ventricular arrhythmia and sudden cardiac death are the most common lethal complications after myocardial infarction. Antiarrhythmic pharmacotherapy remains a clinical challenge and novel concepts are highly desired.
Sadek, Mirna S. +24 more
core +2 more sources
Mexiletine: Antiarrhythmic mechanisms, emerging clinical applications and mortality
Mexiletine, a class Ib antiarrhythmic drug, exhibits its major antiarrhythmic effect via inhibition of the fast and late Na currents in myocardial tissues that are dependent on the opening of Na channels for their excitation.
Tse, Gary +5 more
core +2 more sources
Regulation of gap junction function; the role of nitric oxide. [PDF]
Myocardial ischemia resulting from sudden occlusion of a coronary artery is one of the major causes in the appearance of severe, often life-threatening ventricular arrhythmias.
Kovács Mária +15 more
core +1 more source
Key Clinical Message We report a case of a 71‐year‐old male with severe depression treated with electroconvulsive therapy (ECT) in the operating room complicated by monomorphic ventricular tachycardia (MMVT).
Samuel Su +2 more
doaj +1 more source

